Lynx1 Capital Management’s iBio IBIO Stock Holding History

Lynx1 Capital Management’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$129K	Buy	+68,076	New	+$158K	0.02%	19
2025 Q4	–	Sell	-1,055,897	Closed	-$874K	–	25
2025 Q3	$874K	Sell	1,055,897 -482,676	-31%	-$371K	0.18%	12
2025 Q2	$1.17M	Buy	1,538,573 +676,294	+78%	+$734K	0.34%	12
2025 Q1	$3.47M	Hold	862,279	–	–	1.24%	10
2024 Q4	$2.11M	Hold	862,279	–	–	0.79%	13
2024 Q3	$1.91M	Buy	862,279 +21,516	+3%	+$42.5K	0.68%	9
2024 Q2	$1.77M	Buy	840,763 +240,763	+40%	+$518K	0.64%	11
2024 Q1	$2.44M	Buy	+600,000	New	+$754K	0.63%	12

Other funds holding IBIO

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Lynx1 Capital Management's IBIO Position: Q1 2026 in Review

Lynx1 Capital Management opened a new position in iBio (IBIO) in Q1 2026: 68,076 shares worth $129K. The stake represents 0.02% of the portfolio and ranks #19 among its holdings. This is a return to the name: Lynx1 Capital Management previously reported a position in IBIO as recently as Q3 2025.

Lynx1 Capital Management first reported a position in IBIO in Q1 2024 and has held it in 8 quarters since. The position peaked at $3.47M in Q1 2025. 52 funds tracked by Wall St. Rank hold IBIO as of Q1 2026.

Lynx1 Capital Management held 68,076 shares of iBio worth $129K as of Q1 2026.
iBio was a new Lynx1 Capital Management position in Q1 2026.
iBio made up 0.02% of Lynx1 Capital Management's portfolio in Q1 2026, its #19 holding.
Lynx1 Capital Management first reported a position in iBio in Q1 2024 and has held it in 8 quarters since.
Lynx1 Capital Management's iBio position peaked at $3.47M in Q1 2025.
52 funds tracked by Wall St. Rank held iBio as of Q1 2026.

Based on Lynx1 Capital Management's 13F filing for Q1 2026, filed 4 May 2026.